Core Insights - U.S. LNG exports surged 24% to a record 14.6 Bcf/d in 2025, driven by new capacity and infrastructure projects, despite facing headwinds in 4Q25 due to tightening spreads between global LNG prices and U.S. benchmarks [1][2] U.S. LNG Capacity Expansion - 2025 marked a historic year for U.S. LNG, with exports reaching new highs and approximately 9 Bcf/d of new capacity beginning construction, including major projects from Venture Global, Woodside Energy, and Sempra Infrastructure [1] - LNG exports increased by 26% year-over-year, primarily due to the ramp-up of Venture Global's Plaquemines facility and the completion of Cheniere Energy's Corpus Christi Stage 3 [1] - An additional ~2.4 Bcf/d of capacity is expected to come online in 2026, driven by expansions from VG and Exxon [1] - The only Final Investment Decision (FID) in 4Q25 was for NextDecade's Rio Grande Train 5, while Energy Transfer suspended its Lake Charles LNG project [1] Global Market Headwinds - LNG-related stocks faced pressure in 4Q25, with liquefaction being the worst-performing subsector in the Alerian Midstream Energy Select Index [1] - The spread between European and Asian LNG markers and the U.S. Henry Hub benchmark compressed to multi-year lows of $4-$6 per million British thermal unit (MMBtu) by December [1] - Cheniere Energy, with over 90% of its production contracted long-term, remained insulated from spot price volatility, while Venture Global faced challenges due to its strategy of delaying commercial operations [1] - Cold weather forecasts and declining gas inventories in early 2026 have led to a rebound in global benchmarks, improving margins for LNG exporters [1] Potential Near-Term FIDs - Three LNG projects that were expected to reach FID by the end of 2025 have now pushed their targets into the first half of 2026, including Delfin FLNG, Commonwealth LNG, and Texas LNG [2] - Glenfarne signed a definitive sales and purchase agreement for its Texas LNG project, fully subscribing the project and targeting completion of financing and FID in early 2026 [2] Bottom Line - LNG export projects under construction are set to double U.S. export capacity by 2031, with more projects potentially starting construction soon [2] - While oversupply concerns impacted the market in 4Q25, fundamentals have shown improvement heading into 2026 [2]

Core Viewpoint - Linde plc (NASDAQ:LIN) is recognized as a strong investment opportunity in the materials sector, with analysts maintaining bullish ratings and raising price targets, indicating significant upside potential for investors [1][2]. Group 1: Analyst Ratings and Price Targets - Citi analyst Patrick Cunningham has maintained a Buy rating on Linde plc and increased the price target from $520 to $540, suggesting an upside of nearly 25% from current levels [1]. - BMO Capital reaffirmed its Outperform rating on Linde plc, setting a target price of $501, which translates to an upside potential of approximately 16% for investors [2]. Group 2: Business Growth and Management Insights - Management's recent business review indicates potential for earnings per share (EPS) growth exceeding 10% through various strategies [3]. - An artificial intelligence presentation by management is expected to enhance operational efficiencies and generate cost savings for the company [3]. - Management believes the stock is undervalued following a three-month sell-off, presenting attractive entry points for investors [3]. Group 3: Company Overview - Linde plc is a global leader in industrial gases and engineering solutions, providing a range of atmospheric and process gases, including hydrogen, oxygen, nitrogen, carbon dioxide, helium, and argon [4]. - The company also has a healthcare subsidiary that supplies medical gases for respiratory care, along with offerings in surface coatings, metal powders, and carbon capture [4].

Economic Indicators - The January S&P US manufacturing PMI is expected to increase by +0.2 to 52.0 [1] - The final University of Michigan January US consumer sentiment index is anticipated to remain unchanged at 54.0 [1] - Weekly initial unemployment claims rose by 1,000 to 200,000, better than the expected 209,000 [4] - Q3 GDP was revised upward by 0.1 to 4.4%, exceeding expectations of no change at 4.3% [4] - November personal spending increased by +0.5% month-over-month, aligning with expectations, while personal income rose by +0.3%, below the expected +0.4% [4] - The November core PCE price index rose by +0.2% month-over-month and +2.8% year-over-year, meeting expectations [4] Stock Market Performance - The S&P 500 Index closed up +0.55%, the Dow Jones closed up +0.63%, and the Nasdaq 100 closed up +0.76% [6] - The stock market rally was supported by President Trump's comments on Greenland and strength in chip makers and AI-infrastructure stocks [5][13] - 81% of the 38 S&P 500 companies that reported earnings have beaten expectations, with S&P earnings growth projected to rise by +8.4% in Q4 [7] Sector Movements - Chip makers and AI-infrastructure stocks saw significant gains, with Arista Networks up more than +8% and ARM Holdings up more than +5% [13] - The Magnificent Seven technology stocks also performed well, with Meta Platforms up more than +5% and Tesla up more than +4% [14] - Karman Holdings closed up more than +6% after a strong buy rating was reiterated, while Northern Trust reported Q4 net interest income above consensus [15] Bond Market - March 10-year T-notes closed down by -2 ticks, with the yield rising by +0.6 basis points to 4.249% [10] - European government bond yields increased, with the 10-year German bund yield rising by +0.5 basis points to 2.888% [12]

Core Viewpoint - The liquefied natural gas supplier has successfully defeated Repsol in arbitration, while ongoing disputes with BP and Shell continue [1] Group 1 - The arbitration victory against Repsol highlights the supplier's strong legal position in the industry [1] - The disputes with BP and Shell indicate potential ongoing challenges and complexities in the supplier's business relationships [1]

The market’s focus this week will be on economic news and any fresh tariff developments, the next Fed Chair, and Greenland. On Friday, the Jan S&P US manufacturing PMI is expected to be up by +0.2 to 52.0. Also, the final University of Michigan Jan US consumer sentiment index is expected to be unrevised at 54.0.On Wednesday, President Trump said he would refrain from imposing tariffs on goods from European nations that oppose his effort to acquire Greenland. NATO Secretary General Rutte said a breakthrough ...

Economic Indicators - November personal spending is expected to increase by +0.5% month-over-month, while personal income is projected to rise by +0.4% month-over-month [1] - The November core PCE price index, the Federal Reserve's preferred inflation measure, is anticipated to rise by +0.2% month-over-month and +2.8% year-over-year [1] - The January S&P US manufacturing PMI is expected to increase by +0.2 to 52.0, and the final University of Michigan January US consumer sentiment index is expected to remain unchanged at 54.0 [1] Natural Gas Market - Natural gas prices have surged more than +60% this week, reaching a three-year high, driven by an Arctic cold front that is expected to increase heating demand [3] - Prices rose more than +8% today, boosting stocks of natural gas producers [3] Stock Market Performance - Stocks are maintaining gains due to better-than-expected US economic news, with weekly initial unemployment claims rising by 1,000 to 200,000, lower than the expected 209,000 [4] - Q3 GDP was revised upward by 0.1 to 4.4% quarter-over-quarter annualized, exceeding expectations of no change [4] - The S&P 500 Index is up +0.78%, the Dow Jones Industrials Index is up +0.96%, and the Nasdaq 100 Index is up +0.83% [6] Earnings Season - The Q4 earnings season has begun positively, with 81% of the 38 S&P 500 companies that have reported beating expectations [7] - S&P earnings growth is expected to rise by +8.4% in Q4, with a +4.6% increase expected when excluding the Magnificent Seven technology stocks [7] Stock Movers - Chip makers and AI-infrastructure stocks are leading the market rally, with ARM Holdings up more than +5% and Microchip Technology up more than +3% [14] - The Magnificent Seven technology stocks are also performing well, with Meta Platforms up more than +3% and Alphabet and Tesla up more than +1% [15] - Northern Trust is up more than +7% after reporting Q4 net interest income of $654.3 million, exceeding the consensus of $604.5 million [15] Company-Specific Developments - Venture Global is up more than +6% after winning a dispute with Repsol SA regarding liquefied natural gas shipments [16] - Datadog is up more than +5% following an upgrade from Stifel, with a new price target of $160 [16] - Abbott Laboratories is down more than -7% after reporting Q4 net sales of $11.46 billion, below the consensus of $11.80 billion [18]

Stock futures were rising Thursday and putting equities on course to extend the previous session's rally after President Donald Trump said he struck "the framework of a future deal†with NATO regarding Greenland. ...

Group 1 - Venture Global announced that an arbitration tribunal ruled in its favor in a dispute with Repsol regarding the initial failure to deliver liquefied natural gas [1]

Group 1 - The US IPO market demonstrated strong momentum in 2025, with 371 new stocks listed and a total fundraising amount of $69.764 billion, representing year-on-year increases of 55.23% and 81.53% respectively [1] - Among the 371 new stocks, 145 were SPAC IPOs, raising a total of $26.579 billion, with year-on-year growth of 154.39% and 321.36% [1] - Nasdaq continued to dominate the new stock flow, attracting 80% of new listings and accounting for 67.56% of the total fundraising amount [4] Group 2 - The distribution of fundraising amounts showed that 38% of new stocks raised between $100 million and $300 million, while 23% raised less than $10 million, and only 3% raised over $1 billion, indicating a balanced support for both small and leading enterprises [5] - The top ten fundraising companies included Medline ($6.265 billion), Venture Global ($1.75 billion), and CoreWeave ($1.5 billion), showcasing a diverse range of sectors [7] - The new stock sources exhibited a global characteristic, with Chinese companies contributing nearly 25% of the total new stock quantity, followed by Singapore at 7% [7] Group 3 - The technology and healthcare sectors led the IPO trends, with application software, biopharmaceuticals, and data processing contributing over a quarter of the new stock quantity, reflecting a shift towards high-growth, technology-intensive industries [9] - The significant increase in the number and amount of fundraising in the US stock market in 2025 was driven by active SPACs, the strengthening of Nasdaq's platform effect, and the availability of international listing channels [9]

Core Insights - The US equity financing market in 2025 showed a significant recovery, with total financing reaching $201.8 billion, a 14.27% increase from $176.6 billion in 2024 [1][3][39] - Initial Public Offerings (IPOs) saw a notable rise, with 403 companies going public, raising $68.4 billion, marking a 67.95% increase compared to 2024 [1][14][30] - SPAC IPOs also surged, with 123 companies raising $23.4 billion, a dramatic increase of 153.75% from the previous year [1][33] - Chinese companies listed in the US primarily consisted of small to medium-sized enterprises, totaling 68 IPOs but raising only $1.1 billion, a decrease of 62.88% from 2024 [1][36] Equity Financing Overview - Total equity financing in the US market for 2025 was $201.8 billion, with IPOs contributing $68.4 billion (33.90%) and refinancings accounting for $133.4 billion (66.10%) [3][6] - The non-bank financial sector led in financing, raising $61.9 billion, followed by the pharmaceutical and biotechnology sector at $33.9 billion, and software services at $22.6 billion [9] IPO Market Trends - The IPO market in 2025 was dominated by the Nasdaq, with 313 companies raising $46.04 billion, representing 67.30% of the total IPO market [16] - The highest fundraising sector for IPOs was non-bank financials, raising $34.6 billion, followed by pharmaceuticals at $8 billion, and software services at $7.4 billion [18] - A total of 230 companies raised $1 billion or less in their IPOs, making up 57% of the total IPO count [27] Refinancing Trends - The refinancing market in 2025 totaled $133.4 billion, a slight decrease of 1.82% from 2024, with 912 refinancing events, an increase of 2.36% [39] - The Nasdaq led in refinancing events with 734 occurrences, raising $69.65 billion, while the NYSE had 125 events totaling $62.37 billion [43][45] - The non-bank financial sector was the top industry for refinancing, raising $27.3 billion, followed closely by pharmaceuticals at $25.9 billion [46] Underwriting Rankings - In the IPO underwriting space, Cantor Fitzgerald led with $6.484 billion from 34 deals, followed by Goldman Sachs with $6.354 billion from 36 deals, and Morgan Stanley with $5.956 billion from 35 deals [55][56] - For refinancing, J.P. Morgan topped the list with $21.098 billion from 91 deals, followed by Goldman Sachs with $16.393 billion from 73 deals [59][60]